Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission
Condition(s): Leukemia, Myelocytic, Acute Last Updated: August 19, 2009Completed